Supraglottic Squamous Cell Carcinoma Clinical Trial
Official title:
Treatment of Supraglottic Squamous Cell Carcinoma With Advance Technologies: Observational Evaluation of Quality of Life, Oncological Outcomes, Functional Outcomes and Economical Resources
In this project, the investigators will realize an observational, prospective, multicentric and international clinical trial, to objectively compare patients with SSCC according to 3 arms of treatment: - Arm 1: Radiotherapy ± chemotherapy - Arm 2: Trans-oral Laser Microsurgery (TLM) - Arm 3: Trans-oral Robotic Surgery (TORS) The main goal is to evaluate the efficacy of each treatment with four classes of outcomes: - The quality of life (QoL) before and after each treatment option, using validated questionnaires - Oncological outcomes - Functional outcomes - Economical Resources The population will include cT1-T2 /cN0-N1/M0 supraglottic squamous cell carcinoma. The primary outcome is a Clinical Dysphagia QoL evaluation assessed by the MD Anderson Dysphagia questionnaire. Secondary outcomes include others QoL evaluation, oncological and functional measures and cost parameters. The sample size needs to reach 36 patients per arm (total 108).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03357107 -
Local Control After Robot-assisted Supraglottic Laryngectomy
|
N/A | |
| Recruiting |
NCT02984410 -
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
|
N/A | |
| Active, not recruiting |
NCT01819480 -
Efficacy and Safety of TORS for SCCA
|
N/A |